Hormonal therapies for the adjuvant treatment of early oestrogen-receptor-positive breast cancer
This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta112
8 Review of guidance
8.1 The review date for a technology appraisal refers to the month and year in which the Guidance Executive will consider whether the technology should be reviewed. This decision will be taken in the light of information gathered by the Institute, and in consultation with consultees and commentators.
8.2 The guidance on this technology was considered for review in October 2009. Details are on the NICE website.